Filter Results
Clinical Studies
Results filtered:Study status:
Contact Us for the Latest Status
Contact Us for the Latest Status
-
Expanded Access IND Protocol: Use Of Tecovirimat (TPOXX®) For Treatment Of Human
Orthopoxvirus Infections
Owatonna, Minn.,
Rochester, Minn.,
Red Wing, Minn.,
Lake City, Minn.,
Mankato, Minn.,
Eau Claire, Wis.,
Jacksonville, Fla.,
La Crosse, Wis.,
Scottsdale/Phoenix, Ariz.,
Austin, Minn.,
Cannon Falls, Minn.,
Albert Lea, Minn.
The purpose of this expanded access IND treatment program is to provide tecovirimat for primary or early empiric treatment of confirmed or suspected (based on clinical signs and symptoms with known exposure while laboratory confirmation may be pending) non-variola orthopoxvirus infections (e.g., vaccinia, monkeypox, cowpox or other human virus infection identified as an orthopoxvirus) and secondary treatment of complications from replication competent vaccinia vaccine in adults and children.
.